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is often hampered by lack of overlap in the covariate distributions between treatment groups.
This lack of overlap can lead to imprecise estimates, and can make commonly used estimators
sensitive to the choice of speciﬁcation. In such cases researchers have often used ad hoc methods
for trimming the sample. We develop a systematic approach to addressing lack of overlap. We
characterize optimal subsamples for which the average treatment effect can be estimated most
precisely. Under some conditions, the optimal selection rules depend solely on the propensity
score. For a wide range of distributions, a good approximation to the optimal rule is provided by
the simple rule of thumb to discard all units with estimated propensity scores outside the range
[0·1,0·9].
Some key words: Average treatment effect; Causality; Ignorable treatment assignment; Overlap; Propensity score;
Treatment effect heterogeneity; Unconfoundedness.
1. INTRODUCTION
There is a large literature on estimating average treatment effects under assumptions of uncon-
foundedness or ignorability, following the seminal work by Rubin (1974, 1997), Rosenbaum &
Rubin(1983)andRosenbaum(1989).Researchershavedevelopedestimatorsbasedonregression
methods (Hahn, 1998; Heckman et al., 1998), matching (Rosenbaum, 1989; Abadie & Imbens,
2006) and methods based on the propensity score (Rosenbaum & Rubin, 1983; Hirano et al.,
2003). Related methods for missing data problems are discussed in Robins & Rotnitzky (1995);188 R. K. CRUMP,V .J .H OTZ,G .W .I MBENS AND O. A. MITINIK
see Rosenbaum (2001) and Imbens (2004) for general surveys. An important practical concern
in implementing these methods is the need for overlap in the covariate distributions in the treated
and control subpopulations. Even if the supports of the two covariate distributions are identical,
there may be parts of the covariate space with limited numbers of observations for either the
treatment or control group. Such areas of limited overlap can lead to conventional estimators of
average treatment effects having substantial bias and large variances. Often researchers discard
units for which there is no close counterpart in the subsample with the opposite treatment. The
implementation of these methods is typically ad hoc, with, for example, researchers discarding
units for whom they cannot ﬁnd a match that is identical in terms of the propensity score up to
one, two or even eight digits; see for example Grzybowski et al. (2003)a n dV i n c e n te ta l .(2002).
Weproposeasystematicapproachtodealingwithsampleswithlimitedoverlapinthecovariate
distributions in the two treatment arms. Our proposed method is not tied or limited to a speciﬁc
estimator. It has some optimality properties and is straightforward to implement in practice. We
focus on average treatment effects within a selected subpopulation, deﬁned solely in terms of
covariate values, and look for the subpopulation that allows for the most precise estimation of the
average treatment effect. We show that this problem is, in general, well deﬁned, and, under some
conditions,leadstodiscardingobservationswithpropensityscoresoutsideaninterval[α,1 − α],
with the optimal cut-off value α determined by the marginal distribution of the propensity score.
Our approach is consistent with the common practice of dropping units with extreme values of
the propensity score, with two differences. First, the role of the propensity score in the selection
rule is not imposed a priori, but emerges as a consequence of the criterion, and, second, there is
a principled way of choosing the cut-off value α. The subset of observations is deﬁned solely in
terms of the joint distribution of covariates and the treatment indicator, and does not depend on
the distribution of the outcomes. As a result, we avoid introducing deliberate bias with respect to
the treatment effects being analyzed. The precision gain from this approach can be substantial,
withmostofthegaincapturedbyusingaruleofthumbtodiscardobservationswiththeestimated
propensity score outside the range [0·1,0·9]. The main cost is that some external validity may be
lost by changing the focus to average treatment effects for a subset of the original sample.
We illustrate these methods using data on right heart catheterization from Murphy & Cluff
(1990).
2. THE FRAMEWORK AND A SIMPLE EXAMPLE
2·1. Underlying framework
The framework we use is that of Rosenbaum & Rubin (1983). We have a random sample of
size N from a large population. For each unit i in the sample, let Wi indicate whether or not the
treatment of interest was received, with Wi = 1 if unit i receives the treatment of interest and
Wi = 0 if unit i receives the control treatment. Let Yi(0) denote the outcome for unit i under
control and Yi(1) the outcome under treatment. We observe Wi and Yi,w h e r e
Yi = Yi(Wi) =
 
Yi(0), Wi = 0,
Yi(1), Wi = 1.
In addition, we observe a K-dimensional vector of pre-treatment variables, or covariates, denoted
by Xi, with support X ⊂ RK. Deﬁne the two conditional mean functions, μw(x) = E{Yi(w) |
Xi = x}, the two conditional variance functions, σ2
w(x) = var{Yi(w) | Xi = x}, the condi-
tional average treatment effect τ(x) = E{Yi(1) − Yi(0) | Xi = x}=μ1(x) − μ0(x), and theEstimation of average treatment effects 189
propensity score, the probability of selection into the treatment, e(x) = pr(Wi = 1 | Xi = x) =
E(Wi | Xi = x).






τ(Xi),τ P = E {Yi(1) − Yi(0)}.
The difference between these estimands is important for our analyses, and we return to this in
Remark 1 below. For sets A ⊂ X,l e t1 Xi∈A be an indicator for the event that Xi is an element of










so that τS,X = τS. We denote estimators for the sample and population average treatment effects
by ˆ τ andforthesubsampleaveragetreatmenteffectby ˆ τA.Thereisnoneedtoindextheestimators
by S or P because estimators for the sample average treatment effect are also estimators for the
population average treatment effect.
To solve the identiﬁcation problem, we maintain throughout the paper the following two
assumptions. The ﬁrst, the unconfoundedness assumption (Rosenbaum & Rubin, 1983), asserts
that, conditional on the pre-treatment variables, the treatment indicator is independent of the
potential outcomes. The second assumption ensures overlap in the covariate distributions.
Assumption 1. We assume that Wi ⊥ ⊥{ Yi(0),Yi(1)}|Xi.
Assumption 2. For some c > 0, and all x ∈ X, ce(x)1 − c.
The combination of these two assumptions is referred to as strong ignorability
(Rosenbaum & Rubin, 1983).
2·2. A simple example
Consider the following example in which the covariate is a binary scalar. Suppose that Xi = f ,
female, or Xi = m, male, so that X ={f,m}.F o rx = f,m,l e tNx be the sample size for the
subsample with Xi = x, and let N = N f + Nm be the overall sample size. Also, let p = pr(Xi =
m) be the population proportion of men, with ˆ p = Nm/N. We use the shorthand τx for τS,{x},f o r
x = f,m.L e tNxw be the number of observations with covariate Xi = x and treatment indicator
Wi = w, and let ˆ ex = Nx1/Nx denote the value of the estimated propensity score, for x = f,m.
Finally, let ¯ Yxw =
 
i:Xi=x,Wi=w Yi/Nxw be the average outcome for the four subsamples. We
assume that the distribution of the outcomes is homoscedastic, so that var{Yi(w) | Xi = x}=σ2
for all x = f,m and w = 0,1. The sample and population average effects can be written as τS =
ˆ pτm + (1 − ˆ p)τ f andτP = pτm + (1 − p)τ f.Iftheunconfoundednessassumptionismaintained,
the natural estimators for the average treatment effects for each of the two subpopulations are
ˆ τ f = ¯ Y f 1 − ¯ Y f 0 and ˆ τm = ¯ Ym1 − ¯ Ym0. These estimators are unbiased and conditional on the
covariates and treatment indicators their exact variances are
var
 














ˆ e f(1 − ˆ e f)(1 − ˆ p)
,












ˆ em(1 − ˆ em) ˆ p
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respectively. The natural estimator for the sample, as well as the population, average treatment
effect, is ˆ τ = ˆ pˆ τm + (1 − ˆ p)ˆ τ f. This estimator is unbiased for τS, conditional on X and W,a n d
unbiased, unconditionally, for τP. The conditional variance of ˆ τ is





ˆ em(1 − ˆ em)
+
1 − ˆ p
ˆ e f(1 − ˆ e f)
 
.
It follows that the variance of N1/2(ˆ τ − τS) converges to














The asymptotic unconditional variance of ˆ τ, that is, the asymptotic variance of N1/2(ˆ τ − τP), is




+ (τX − τP)2
 
.( 2 )
Now let us turn to estimators for subpopulation average treatment effects of the type τS,A.T h e
key result of the paper concerns the comparison of var(ˆ τA | X,W) for different sets A, according
to a variance minimization criterion. Let A be the set of all subsets of X, excluding the empty
set. Then we are interested in the set ˆ A that solves
var(ˆ τˆ A | X,W) = inf
A∈A
var(ˆ τS,A | X,W). (3)
In the binary covariate example considered in this section, X ={f,m}, so that A =
{{ f },{m},{ f,m}}, and the problem simpliﬁes to ﬁnding the set ˆ A that solves
var(ˆ τˆ A | X,W) = min
 
var(ˆ τ | X,W),var(ˆ τ f | X,W),var(ˆ τm | X,W)
 
.





{ f }, ˆ em(1 − ˆ em)/
 
ˆ e f(1 − ˆ e f)
 
<(1 − ˆ p)/(2 − ˆ p),
X, (1 − ˆ p)/(2 − ˆ p) ˆ em(1 − ˆ em)/
 
ˆ e f(1 − ˆ e f)
 
< (1 + ˆ p)/ ˆ p,
{m}, (1 + ˆ p)/ ˆ p ˆ em(1 − ˆ em)/
 




Remark 1. We compare the conditional, not the unconditional, variances in (3), and so we
compare objects like the right-hand side of (1) rather than the right-hand side of (2). Since the
asymptotic unconditional variance of ˆ τ, given in (2), depends on the conditional treatment effects
τ f and τm through the term E{(τX − τP)2}, comparisons of the unconditional variances would
make the optimal set depend on the value of the treatment effects. This has two disadvantages.
First, it makes the optimal set depend on the distribution of the potential outcomes, rather than
solely on the distribution of treatment and covariates, thus opening the door to potential biases.
Second,implementingtheimpliedcriterionintheunconditionalcasewouldbeconsiderablymore
difﬁcult in practice because the lack of overlap that leads to the difﬁculties in precise estimation
of τP implies that precise estimation of some of the conditional treatment effects τx, and thus the
unconditional variance, would be difﬁcult.
Remark 2. One can also deﬁne the population version of the set ˆ A, denoted by A∗, as the





{ f }, em(1 − em)/
 
e f(1 − e f)
 
<(1 − p)/(2 − p),
X, (1 − p)/(2 − p)em(1 − em)/
 
e f(1 − e f)
 
< (1 + p)/p,
{m}, (1 + p)/pem(1 − em)/
 
e f(1 − e f)
 
.
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The set ˆ A is a natural estimator for A∗, and as a result τS,ˆ A is a natural estimator for τS,A∗.
However, we focus on the asymptotic variance of N1/2(ˆ τˆ A − τS,ˆ A) rather than the asymptotic
variance of N1/2(ˆ τˆ A − τS,A∗); that is, we focus on the uncertainty of the estimator for the average
effect conditional on the set we selected. This greatly simpliﬁes the subsequent analysis, as we
canselectthesampleandthenproceedtoestimatetheaveragetreatmenteffectanditsuncertainty,
ignoring the ﬁrst stage in which the sample was selected. In the binary covariate case it is again
straightforwardtoseewhythissimpliﬁestheanalysis.Denotetheestimatedconditionalvariances
for ˆ τ f,ˆ τm and ˆ τ by
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ˆ V f, ˆ em(1 − ˆ em)/
 
ˆ e f(1 − ˆ e f)
 
<(1 − ˆ p)/(2 − ˆ p),
ˆ VS, (1 − ˆ p)/(2 − ˆ p) ˆ em(1 − ˆ em)/
 
ˆ e f(1 − ˆ e f)
 
< (1 + ˆ p)/ ˆ p,
ˆ Vm, (1 + ˆ p)/ ˆ p ˆ em(1 − ˆ em)/
 




Then ˆ V −1
ˆ A (ˆ τˆ A − τS,ˆ A) −→ N(0,1) in distribution. In this case, N1/2(τS,ˆ A − τS,A∗) may in fact
diverge, if for example one of the inequalities in (6) is an equality so that ˆ A does not converge to
A∗,a n dN1/2(τS,ˆ A − τS,A∗)d i v e r g e s .
In the remainder of the paper, we generalize the above analysis to the case with a vector
of continuously distributed covariates. Then the set A of subsets of X is not countable, and in
addition, for a particular subset A ∈ A there is not a simple estimator, nor can we calculate exact
variances for any estimator. We therefore compare asymptotic variances for efﬁcient estimators.

















A denotes any semiparametric efﬁcient estimator for τS,A.F o rA∗ the average treatment
effect is at least as accurately estimable as that for any other subset of the covariate space. This
leadstoageneralizationof(5).Undersomeregularityconditions,thisproblemhasawell-deﬁned
solution and, under the additional assumption of homoscedasticity, these subpopulations have a
very simple characterization, namely the set of covariate values such that the propensity score
is in the closed interval [α,1 − α], or A∗ ={ x ∈ X | α e(x)1 − α}. The optimal value of
the boundary point α is determined by the marginal distribution of the propensity score, and its
calculation is straightforward. We then estimate this set by ˆ A ={ x ∈ X | ˆ α  ˆ e(x)1 − ˆ α},a n d
propose using any of the standard methods for estimation of, and inference for, average treatment
effects, using only the observations with covariate values in this set, ignoring the uncertainty in
the estimation of the set ˆ A.
3. ALTERNATIVE ESTIMANDS
3·1. Efﬁciency bounds
We now derive the subset of the covariate space that allows for the most precise estimation of
the corresponding average treatment effect.192 R. K. CRUMP,V .J .H OTZ,G .W .I MBENS AND O. A. MITINIK
In this subsection, we discuss some results on efﬁciency bounds for average treatment effects
given strong ignorability and regularity conditions involving smoothness. Deﬁne the sample







withtheweightfunctionω : X  → [0,∞).TheresultsinHahn(1998),Robins & Rotnitzky(1995)








































ψω(Yi,Wi, Xi) + op(N−1/2),
and the efﬁciency bound is the variance of the inﬂuence function, V eff
ω = E{ψω(Y,W, X)}2.
3·2. The optimal subpopulation average treatment effect
WenowconsidertheproblemofselectingtheestimandτS,ω,orequivalentlytheweightfunction
ω(·), that minimizes the asymptotic variance in (7), within the set of estimands where the weight
function ω(x) is an indicator function, ω(x) = 1x∈A; in the working-paper version of this paper,
we also consider the problem without imposing this restriction. Formally, we choose an estimand































          X ∈ A
 
.
We seek A = A∗, which minimizes V eff
A among all closed subsets A ⊂ X.
Focusing on estimands that average the treatment effect only over a subpopulation has two
effectsontheasymptoticvariance,pushingitinoppositedirections.First,byexcludingunitswith
covariate values outside the set A, one reduces the effective sample size in expectation from N to
Nq(A).Thiswillincreasetheasymptoticvariancebyafactor1/q(A).Second,bydiscardingunits
with high values for σ2
1(X)/e(X) + σ2
0(X)/{1 − e(X)} one can lower the conditional expectation
E[σ2
1(X)/e(X) + σ2
0(X)/{1 − e(X)}|X ∈ A]. Optimally choosing A involves balancing these
two effects.
THEOREM 1. Suppose that Assumptions 1–2 hold, that the density of X is bounded away from
zero and inﬁnity, and that the conditional variances of Yi(0) and Yi(1) are bounded. We considerEstimation of average treatment effects 193
τS,A,w h e r eA is a closed subset of X. Then the optimal subpopulation average treatment effect is
















     






































A sketch of the proof is given in the Appendix.











       
  X ∈ A
 
,
be the asymptotic variance under homoscedasticity.
COROLLARY 1. Suppose that Assumptions 1–2 hold and that the density of X is bounded away
from zero and inﬁnity. Suppose also that σ2
w(x) = σ2 for all w ∈{ 0,1} and x ∈ X. Then the
optimal subpopulation average treatment effect is τS,A∗
H,w h e r e
A∗












then α = 0 and A∗
















This is the key result in the paper. In practice it is more useful than the result in Theorem 1 for
two reasons. First, the optimal set A∗
H depends only on the marginal distribution of the propensity
score, and so its construction avoids potential biases associated with using outcome data. Second,
the criterion in Corollary 1 is more easily implemented because the propensity score can be
precisely estimable, even in settings with little overlap, whereas the conditional variances that
appear in the criterion in Theorem 1 may not be. Even when homoscedasticity does not hold, the
optimal set according to this criterion may be a useful approximation.
To implement our proposed criterion, one would ﬁrst estimate the propensity score. In the









ˆ e(Xi){1 − ˆ e(Xi)}
 
 N
i=1 1ˆ e(Xi){1−ˆ e(Xi)}α(1−α)
,
and use the set ˆ A = {x ∈ X | ˆ α  ˆ e(x)1 − ˆ α}. Given this set ˆ A one would use one of the
standard methods for estimation of, and inference for, average treatment effects, such as those194 R. K. CRUMP,V .J .H OTZ,G .W .I MBENS AND O. A. MITINIK
Table 1. Variance ratios for beta distributions
γ
β 0·51 ·02 ·04 ·0
0·5 VS(γ,β)/VS,α∗(γ,β)1 3 ·38 11·68 13·71 12·83
VS,0·01(γ,β)/VS,α∗(γ,β)1 ·70 1·64 1·71 1·58
VS,0·10(γ,β)/VS,α∗(γ,β)1 ·00 1·00 1·00 1·04
1·0 VS(γ,β)/VS,α∗(γ,β)2 ·68 2·65 3·36
VS,0·01(γ,β)/VS,α∗(γ,β)1 ·39 1·39 1·47
VS,0·10(γ,β)/VS,α∗(γ,β)1 ·00 1·00 1·01






surveyed in Rosenbaum (2001)a n dImbens (2004), ignoring the uncertainty in the estimation
of ˆ A.
3·3. Numerical simulations for optimal estimands when the propensity score follows
a beta distribution
In this section, we assess the implications of the results derived in the previous sections
by presenting simulations for the optimal estimands, under homoscedasticity, when the true
propensity score follows a beta distribution. For a beta distribution with parameters β and γ,
the mean is β/(γ + β) ∈ [0,1], and the variance is βγ/{(γ + β)2(γ + β + 1)}∈[0,1/4]. We
focus on distributions for the true propensity score, with β ∈{ 0·5,1,2,4} and γ ∈{ β,...,4}.
For a given pair of values (β,γ), let V eff
S (β,γ) denote the asymptotic variance of the efﬁcient
estimator for the sample average treatment effect,
V eff







       e(X) ∼ Be(β,γ)
 
.
In addition, let V eff
S,α(β,γ) denote the asymptotic variance for the efﬁcient estimator for the
sample average treatment effect, where we drop observations with the propensity score outside








 α e(X)1 − α,e(X) ∼ Be(β,γ)]
pr{α e(X)1 − α|e(X) ∼ Be(β,γ)}
.
Let α∗ denote the optimal cut-off value that minimizes V eff
S,α(β,γ). For each of the (β,γ)p a i r s ,












on the distribution of the propensity score. Second, discarding observations with a propensity
score outside the interval [0·1,0·9] produces variances that are extremely close to those produced
with optimally chosen cut-off values for the range of beta distributions considered here. InEstimation of average treatment effects 195







































































contrast, using the smaller ﬁxed cut-off value of 0·01 can lead to considerably larger variances
than using the optimal cut-off value.
4. A REANALYSIS OF DATA ON RIGHT HEART CATHETERIZATION
Connors et al. (1996) used a propensity score matching approach to study the effectiveness of
right heart catheterization in an observational setting, using data from Murphy & Cluff (1990).
Right heart catheterization is a diagnostic procedure used for critically ill patients. The study col-
lecteddataonhospitalizedadultpatientsatﬁvemedicalcentresintheU.S.A.Basedoninformation
from a panel of experts, a rich set of variables relating to the decision to perform the right heart
catheterization was collected, as well as detailed outcome data. Detailed information about the
study and the nature of the variables can be found in Connors et al. (1996)a n dMurphy & Cluff
(1990). Connors et al. (1996) found that, after adjustment for ignorable treatment assignment
conditional on a range of covariates, right heart catheterization appeared to lead to lower sur-
vival rates. This conclusion contradicted popular perception among practitioners that right heart
catheterization was beneﬁcial. The primary analysis in Connors et al. (1996) matched treated and




the outcome, which is an indicator for survival at 30 days, and 72 covariates. For summary
statistics on the 72 covariates, see Connors et al. (1996)a n dHirano & Imbens (2001). The two
treatment groups differ on many of the covariates in statistically and substantially signiﬁcant
ways. We estimate the propensity score, using a logistic model that includes all 72 covariates.
Hirano & Imbens (2001) study various methods for selecting subsets of the covariates. Figure 1
shows the distribution of estimated propensity scores. While the two groups obviously differ, the
support of the estimated propensity scores in both groups is nearly the entire unit interval.
Basedontheestimatedpropensityscore,wecalculatetheoptimalcut-offvalueα inCorollary1,
obtaining ˆ α = 0·1026. Next, we consider three samples, (i) the full sample, (ii) the set of units196 R. K. CRUMP,V .J .H OTZ,G .W .I MBENS AND O. A. MITINIK
Table 2. Subsample sizes for right heart catheterization
data
ˆ e(Xi) < 0·10 ·1 ˆ e(Xi)0·90 ·9 < ˆ e(Xi)A l l
Controls 870 2671 10 3551
Treated 40 2057 87 2184
All 910 4728 97 5735
Table 3. Estimates for average treatment effects in
right heart catheterization study
Estimate SE(1) SE(2)
Full sample −0·0593 0·0166 0·0167
ˆ e(Xi) ∈ [0·1,0·9] −0·0590 0·0143 0·0143
ˆ e(Xi) ∈ [0·1026,0·8974] −0·0601 0·0143 0·0144
with ˆ e(Xi) ∈ [0·1,0·9], based on the 0·1 rule-of-thumb, and (iii) the optimal set with ˆ e(Xi) ∈
[0·1026,0·8974]. In Table 2 we report the sample sizes by treatment status in the [0·1,0·9]
dataset.
Next we estimate the average effect and its variance for each subsample. The speciﬁc estimator
we use in each case is a version of the Horvitz–Thompson (1952) estimator; see Hirano et al.
(2003)fordetailsoftheimplementation.First,were-estimatethepropensityscoreontheselected














1 − ˆ e(Xi)
  N  
i=1
1 − Wi
1 − ˆ e(Xi)
.
We estimate the standard errors using the bootstrap, given the sample selected. We use two
estimators. First, we simply calculate the standard deviation of the B bootstrap replications.
This estimator is denoted by SE(1). Second, given the ordered B bootstrap estimates, we take
the difference between the 0·95 × B and the 0·05 × B bootstrap estimates and divided this
difference by 2 × 1·645 to obtain an estimate for the standard error. This estimator is denoted
by SE(2). These standard error estimators do not impose homoscedasticity, which was only
used in the construction of the optimal set. We use 50000 bootstrap replications and Table 3
presents the results. For both the [0·1,0·9] sample and the optimal [0·1026,0·8974] sample, the
variance drops to approximately 64% of the original variance. Thus, by dropping 18% of the
sample, we obtain a sizeable reduction in the variance of 36%. These results further strengthen
the substantive conclusions in Connors et al. (1996) that right heart catheterization has negative
effects on survival.
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i:Xi∈A
ω(Xi),
for functions ω(·):X  → [0,∞). For estimands of this type, consider the minimum asymptotic variance













[E {ω(X)1X∈A}]2 .( A 1 )
We are interested in the choice of set A that minimizes (A1) among the set of all closed subsets of X.
The following theorem provides the characterization. Let f (·) be the probability density function of the
covariate X.
THEOREM A1. Suppose that fl  f (x) fu, that σ2(x)σ2
u for w = 0,1 and all x ∈ X, and that

















































































Sketch of proof . Deﬁne
k(x) = σ2
1(x)/e(x) + σ2




and ˜ ω(x) = ω(x)/
 
z fX(z)ω(z)dz,sothatk(x)isbounded away fromzeroandinﬁnity, andiscontinuously
differentiable on X.L e t ˜ X be a random vector with probability density function ˜ fX(x)o nX, and let
˜ q(A) = pr( ˜ X ∈ A). Then
















˜ ω( ˜ X)1 ˜ X∈Ak( ˜ X)
 
.
Since multiplying ω(x) by a constant does not change the value of the objective function in (A1), we have



















˜ ω( ˜ X)k( ˜ X)
   1 ˜ X∈A
 
.( A 2 )198 R. K. CRUMP,V .J .H OTZ,G .W .I MBENS AND O. A. MITINIK
Thus the question now concerns the set A that minimizes (A2).
The remainder of the proof of Theorem A1 consists of two stages. First, suppose there is a closed set
A such that x ∈ int(A), z / ∈ A, and ˜ ω(z)k(z) < ˜ ω(x)k(x). Then we will construct a closed set ˜ A such that
VS,˜ ω(˜ A) < VS,˜ ω(A).This implies that theoptimal sethas theform A∗ ={ x ∈ X | ˜ ω(x)k(x)δ},forsome
δ. The second step consists of deriving the optimal value for δ.
For the ﬁrst step deﬁne a ball around x with volume ν,
Bν(x) =
 
z ∈ X| z − x ν1/L2−1/Lπ−1/2 (L/2)1/L 
.
Now we construct the set Aν ={ A ∩ Bν/ ˜ fX(x)(x)}∪Bν/ ˜ fX(z)(z). For small enough ν,






˜ ω( ˜ X)k( ˜ X)




˜ ω( ˜ X)k( ˜ X)
    ˜ X ∈ Bν/ ˜ fX(x)(x)
  
+ o(ν).
Since E{˜ ω( ˜ X)k( ˜ X) | ˜ X ∈ Bν/ ˜ fX(z)(z)}−E{˜ ω( ˜ X)k( ˜ X) | ˜ X ∈ Bν/ ˜ fX(x)(x)} < 0i fν ν0, the difference
VS,˜ ω(Aν) − VS,˜ ω(A) is negative for small enough ν.
The issue now is to determine the optimal value for δ, given that the optimal set has the form Aδ ={ x ∈





   δ
0 fY(y)dy
 2.
Either VS,˜ ω(Aδ) is minimized at δ = supx∈X k(x), or there is an interior minimum where the ﬁrst-
order conditions are satisﬁed. The latter implies that δ = 2E{˜ ω( ˜ X)k( ˜ X) | ˜ ω( ˜ X)k( ˜ X) <δ }, and thus
γ = 2E{ω( ˜ X)k( ˜ X) | ω( ˜ X)k( ˜ X) <γ},f o rγ = δ
 
ω(x) fX(x)dx. This in turn implies that
γ = 2
E{ω2(X)k(X) | ω(X)k(X) <γ}
E{ω(X) | ω(X)k(X) <γ}
.
If we substitute back k(x) = σ2
1(x)/e(x) + σ2
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